wRight to the Root

Corporate Greed vs. Patient Care: The Illusion of Coverage

12 min · 6 de abr de 2026
portada del episodio Corporate Greed vs. Patient Care: The Illusion of Coverage

Descripción

We’ve been sold the idea that insurance protects us. In this powerful talk, Stephanie Wright uncovers how “coverage” is often an illusion; where algorithms override doctors, patients are left with the bill, and corporate profits come first. From her own cancer journey to real-world patient stories, she exposes a system that benefits from confusion and silence and shows how speaking up is the one thing it can’t control.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y forma parte de la comunidad de wRight to the Root!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

21 episodios

episode Insulin Under Fire, Diabetes Care in Crisis Zones with MSF’s Dr. Phillipa Boulle artwork

Insulin Under Fire, Diabetes Care in Crisis Zones with MSF’s Dr. Phillipa Boulle

On this episode of wRight to the Root, Stephanie Wright sits down with Dr. Phillipa Boulle, a non-communicable disease (NCD) advisor with Doctors Without Borders (MSF) Switzerland, based in Geneva, to expose what it really takes to treat chronic illness in the middle of crisis. Dr. Boulle breaks down the growing global diabetes emergency, including why the vast majority of people living with diabetes are in low and middle income countries, and why sub-Saharan Africa is experiencing the fastest rise. She explains how MSF teams work to deliver care in war zones, displacement camps, and protracted humanitarian emergencies, where access to insulin, monitoring supplies, and even consistent food can disappear overnight. This conversation goes straight to the root of the problem, including: * Why insulin access is still dangerously limited and overpriced, especially for people with type 1 diabetes who need it to survive * The hidden crisis of missing glucose monitoring tools, making insulin use far more dangerous in humanitarian settings * How emergencies like Gaza reveal life-threatening gaps in continuity of care when people are forced to flee repeatedly * MSF research showing insulin can remain stable at higher temperatures than labels suggest, changing what is possible in settings without refrigeration * The double standard in diabetes care, and why patients in the harshest conditions often get the hardest-to-use tools * What’s at stake in the UN High-Level Meeting on NCDs (September in New York), and why emergency diabetes care must be explicitly included * How patient advocacy and government pressure can shift corporate behavior, and how Americans can support global health equity A powerful, grounded conversation about survival, dignity, and the urgent fight to treat healthcare as a human right, not a business.

12 de feb de 202645 min
episode Inside the World Medical Association with Dr. Ashok Philip, WMA President artwork

Inside the World Medical Association with Dr. Ashok Philip, WMA President

I flew all the way to Montevideo, Uruguay to sit down face-to-face with Dr. Ashok Philip (Malaysia), President of the World Medical Association, and this conversation goes straight to the root of why healthcare systems keep failing the people they are supposed to serve. The World Medical Association (WMA) was born in the shadow of the Nuremberg Trials and the medical atrocities of WWII, and that origin story still shapes its mission today: defend medical ethics, protect physician independence, and advocate for patients across borders. Dr. Philip breaks down what the WMA actually does, why it is often confused with the WHO (it is not the WHO), and how a global network of 115 member medical associations tries to push back when governments, corporations, and insurers prioritize “quick and cheap” over what patients truly need. If you have ever felt powerless watching insurance denials, bureaucratic delays, cookie-cutter care, or political posturing hijack medicine, this episode will hit home. And if you are a clinician, this is your reminder that policy is not optional, it is where patient outcomes are decided. In this episode, we unpack: * Why the WMA was founded, and why ethics still sits at the center of global medicine * How private insurance denials and administrative burden are not “just an American problem” * Why prevention and health literacy are always “unsexy,” but essential * Universal healthcare realities, including rationing, access gaps, and technology tradeoffs * How to mobilize younger clinicians, including the WMA’s junior doctors network * AI in medicine, misinformation, and why “tools” still require human accountability * Brain drain from developing countries, and what a fair global solution could look like 🎧 Press play for a rare, behind-the-scenes look at global medicine from the top, and the urgent message Dr. Philip keeps returning to: if we do not address the root cause, we are just managing collapse. If this episode moves you, follow the show, leave a rating, and share it with one person who needs to hear that change is possible, and collective.

28 de ene de 202637 min
episode Diabetes, Dollars, and Power: The Fight For Affordable Insulin. artwork

Diabetes, Dollars, and Power: The Fight For Affordable Insulin.

In this episode of wRight To The Root, Stephanie Wright is joined by Candice Sehoma, a Johannesburg-based access advisor with Doctors Without Borders (MSF), to unpack the global insulin access crisis and why a medication that has existed for over 100 years is still priced, patented, and distributed like a luxury. Candace shares how growing up in Alexandra, a historically marginalized township shaped by apartheid, fueled her commitment to structural change, not charity. Together, we dig into what keeps insulin and diabetes medicines out of reach, including patent systems that protect monopolies, supply decisions that can trigger shortages, and a market that increasingly prioritizes high-profit GLP-1 drugs while basic diabetes care gets squeezed. We also talk about the real path forward, from policy reform and competition enforcement, to local and regional manufacturing, to grassroots organizing and treatment literacy so patients and communities can advocate with power and clarity. If you have ever wondered why life-saving medicine can be marketed like candy and rationed like gold, this conversation is for you. Listen, share, and take action, because patients united are harder to ignore.

14 de ene de 202632 min
episode Medicare Advantage or Medicare Disadvantage? Dr. Ed Weisbart on Denials, Delays & Single Payer artwork

Medicare Advantage or Medicare Disadvantage? Dr. Ed Weisbart on Denials, Delays & Single Payer

On this episode of wRight To The Root, Stephanie Wright sits down with Dr. Ed Weisbart — a retired family medicine physician, former Chief Medical Officer at Express Scripts, and longtime healthcare advocate with Physicians for a National Health Program (PNHP). Dr. Weisbart shares what pushed him from fighting for patients in the exam room to fighting for them in the streets and in policy: years of watching people delay or skip care because of copays, deductibles, denials, and fear of medical debt. Together, Stephanie and Dr. Weisbart unpack why “getting sick” in America has become financially terrifying — and how prior authorization, Medicare Advantage, and corporate profiteering are shaping who gets care and when. You’ll hear a powerful real-life example of how traditional Medicare vs. Medicare Advantage can mean the difference between next-day testing and weeks of delay — delays that, for many patients, can be life-or-death. The conversation also tackles the biggest myths that stall progress (especially the fear of taxes), and why multiple analyses show Medicare for All could cover everyone with no copays or deductibles for the same or less than we already pay. This episode connects the dots between healthcare access, corporate greed, and democracy — while offering real hope: new momentum in Congress, growing coordination among advocacy organizations, and a clear message for both patients and clinicians—silence won’t change the system, but collective action can. If you’ve ever been denied care, overwhelmed by bills, or told to “wait for approval,” this conversation is for you.

31 de dic de 202547 min